Determinants of COVID-19 vaccine hesitancy in French hospitals.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 07 04 2021
revised: 11 07 2021
accepted: 27 08 2021
pubmed: 8 9 2021
medline: 9 11 2021
entrez: 7 9 2021
Statut: ppublish

Résumé

COVID-19 vaccines have become the new hope for stemming the pandemic. We aimed to assess pre-launch vaccine acceptance among hospital workers in the Auvergne-Rhône-Alpes Administrative Region of France. We performed a cross sectional study involving all hospital workers in 11 Auvergne-Rhône-Alpes hospitals in December 2020. Univariate and multivariate analyses were performed to identify factors associated with vaccine hesitancy. We analyzed completed questionnaires from 1,964 respondents (78% women, mean age 42 years, 21.5% physicians, 41% private care centers). A total of 1,048 (53%) hospital workers were in favor of COVID-19 vaccination. Vaccine hesitancy was associated with: female gender; young age; paramedical, technical, and administrative professions (i.e., all non-medical professions); no prior flu vaccination; and employment in the private medical care sector (p<0.05). Distrust of health authorities and pharmaceutical lobbying were the main obstacles to vaccination. Inversely, creating herd immunity and protecting patients and household members were the most frequently cited reasons in favor of vaccination. More than two-thirds of participants feared that the clinical and biological research was too rapid and worried about serious adverse effects. Most participants were interested in written information on the available vaccines, but the most vaccine-hesitant categories preferred oral information. Only 35% supported mandatory vaccination. Targeted written and oral information campaigns will be necessary to improve vaccination coverage among hospital workers who show a surprisingly high hesitancy rate. Imposing mandatory vaccination could be counterproductive.

Identifiants

pubmed: 34492344
pii: S2666-9919(21)00488-7
doi: 10.1016/j.idnow.2021.08.004
pmc: PMC8418382
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

647-653

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

C Navarre (C)

Infectiologie, Centre Hospitalier de Valence, 179, avenue du Maréchal Juin, 26953 Valence, France; Université Claude Bernard Lyon 1, 43, boulevard du 11 Novembre 1918, 69622 Villeurbanne cedex, France. Electronic address: chloe.navarre.cn@gmail.com.

P Roy (P)

Université Claude Bernard Lyon 1, 43, boulevard du 11 Novembre 1918, 69622 Villeurbanne cedex, France; Laboratoire de Biométrie et Biologie Évolutive, CNRS UMR 5558, Villeurbanne, France; Service de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, 69003 Lyon, France.

S Ledochowski (S)

Réanimation polyvalente, Centre Hospitalier Pierre Oudot, 30, avenue du Médipôle, BP 40348, 38302 Bourgoin-Jallieu cedex, France.

M Fabre (M)

Maladies infectieuses, Centre Hospitalier Pierre Oudot, 30, avenue du Médipôle, BP 40348, 38302 Bourgoin-Jallieu cedex, France.

A Esparcieux (A)

Infectiologie, Clinique de l'Infirmerie Protestante de Lyon, 1-3, chemin du Penthod, 69300 Caluire et Cuire, France.

B Issartel (B)

Médecine Interne et Maladies Infectieuses, Médipôle Lyon-Villeurbanne, Médipôle Hôpital Mutualiste, 158, rue Léon Blum, 69100 Villeurbanne, France.

M Dutertre (M)

Médecine Interne et Maladies Infectieuses, Médipôle Lyon-Villeurbanne, Médipôle Hôpital Mutualiste, 158, rue Léon Blum, 69100 Villeurbanne, France.

A-L Blanc-Gruyelle (AL)

Infectiologie, Clinique de l'Infirmerie Protestante de Lyon, 1-3, chemin du Penthod, 69300 Caluire et Cuire, France; Médecine Interne et Maladies Infectieuses, Médipôle Lyon-Villeurbanne, Médipôle Hôpital Mutualiste, 158, rue Léon Blum, 69100 Villeurbanne, France.

F Suy (F)

Médecine Interne et Maladies Infectieuses, Médipôle Lyon-Villeurbanne, Médipôle Hôpital Mutualiste, 158, rue Léon Blum, 69100 Villeurbanne, France.

L Adelaide (L)

Infectiologie, Centre Hospitalier de Vienne-Lucien HUSSEL, Montée du Docteur Chapuis, 38200 Vienne, France.

C Pariset (C)

Infectiologie, Centre Hospitalier Saint Joseph Saint Luc, 20, quai Claude Bernard, 69007 Lyon, France.

J P Kisterman (JP)

Infectiologie, Centre Hospitalier de Macon, 350, boulevard Louis Escande, 71018 Macon, France.

H Champagne (H)

Infectiologie, Centre Hospitalier de Valence, 179, avenue du Maréchal Juin, 26953 Valence, France.

J Saison (J)

Infectiologie, Centre Hospitalier de Valence, 179, avenue du Maréchal Juin, 26953 Valence, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH